UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
(Amendment No. 1)
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report
(Date of earliest event reported): April 21, 2021
(
| (Exact Name of Registrant as Specified in Charter) |
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
|
| (Address of principal executive offices) |
| ( |
| (Registrant’s Telephone Number, Including Area Code) |
| NOT APPLICABLE |
| (Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
On October 5, 2020, AMN Healthcare Services, Inc., a Delaware corporation (the “Company”), filed a current report on Form 8-K (the “Original Filing”) disclosing that its Board of Directors (the “Board”) elected Rear Admiral Dr. Sylvia Trent-Adams, PhD, RN, FAAN as a new director, effective October 1, 2020. At the time of her election, the Board did not make a determination regarding Dr. Trent-Adams' appointment to any committee of the Board.
This Amendment No. 1 on Form 8-K/A amends the Original Filing to include additional information regarding Dr. Trent-Adams’ appointment to the Board and should be read in conjunction with the Original Filing.
Section 5 — Corporate Governance and Management
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On April 21, 2021, the Board appointed Dr. Trent-Adams to its Compensation Committee and its Corporate Governance and Compliance Committee, having previously determined that she satisfies all applicable requirements of the New York Stock Exchange Listed Company Manual and the Securities Exchange Act of 1934, as amended, to serve on such committees.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AMN Healthcare Services, Inc. | |||
Date: April 23, 2021 |
By: | /s/ Susan R. Salka | |
| Susan R. Salka | |||
Chief Executive Officer |
|||